GlaxoSmithKline PLC News Headlines

GSK 
$41.25
*  
0.04
0.1%
Get GSK Alerts
*Delayed - data as of Aug. 28, 2015  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Come Hell Or High Water In The U.S. Shutdown And Debt
10/11/2013 3:33:00 PM - Seeking Alpha




Amgen: GSK's Promacta Stealing Nplate's Thunder
10/11/2013 11:47:00 AM - Seeking Alpha


How To Play Agenus, Both Short Term And Long Term
10/10/2013 2:52:00 PM - Seeking Alpha








Novartis - Make Money From COPD Opportunity
10/7/2013 1:59:00 PM - Seeking Alpha


Time To Invest In British Stocks?
10/6/2013 4:25:00 AM - Seeking Alpha


Drop The Anchor And Fish For Profits
10/2/2013 9:25:00 AM - Seeking Alpha




Diadexus, Back To The Future
9/29/2013 2:54:00 PM - Seeking Alpha


A Promising Future For Anthera's Blisibimod
9/27/2013 5:58:00 PM - Seeking Alpha


The Billion Dollar Molecule
9/26/2013 5:43:00 PM - Seeking Alpha


Is It Time To Go Long Sarepta Therapeutics?
9/26/2013 2:34:00 PM - Seeking Alpha


3 Biotech Stocks To Trade But For Different Reasons
9/24/2013 1:19:00 PM - Seeking Alpha




This Amarin Bear Is Throwing In The Towel
9/23/2013 11:07:00 AM - Seeking Alpha


Prosensa: One Duchenne Therapy Down
9/20/2013 11:05:00 AM - Seeking Alpha


IPO Preview: Five Prime Therapeutics
9/17/2013 4:34:00 PM - Seeking Alpha


DiaDexus Awaiting GSK's Darapladib Pivotal Results
9/17/2013 1:36:00 PM - Seeking Alpha


Epizyme: The Promise Of Personalized Cancer Therapy
9/15/2013 8:21:00 PM - Seeking Alpha


Amarin's Problems Just Went From Bad To Worse
9/13/2013 12:32:00 AM - Seeking Alpha


Neurocrine And ChemoCentryx: Phase II Data Disappoints
9/11/2013 10:48:00 AM - Seeking Alpha